AzTrials
AzTrials

MalnutritionNCT03319589

Pilot Study on a Locally Prepared Food Supplement to Support Growth and Brain Health

A study testing Supplement in people with Malnutrition, run by Tufts University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is a randomized controlled pilot for a future larger trial. The goals of this pilot are: a) to assess feasibility of delivering a locally prepared supplement in rural communities, and b) to generate pilot data for sample size estimates needed for a larger trial. Read more about this study

Who is it for?
Ages 24 to 84 monthsHealthy volunteers can take part
Conditions the study is for
Malnutrition
What is being tested?
Supplement
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteUnited States
Study dates
Mar 2016to Jul 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 24 to 84 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Non-malnourished children within the 2 villages chosen for study
  • Within the specified age range: 24-36 months for young children and 6-7 years for older children, who will also be enrolled in their local school. In the event that researchers cannot enroll at least 15 participants in each age range in each village, will extend the age range up to 35.99 months for young children and up to 6.99 years for older children.
  • The family plans to remain in the village for the duration of the study;
  • The child does not have any known food allergies as reported by the mother or guardian.

Who cannot join

  • If any child is identified as malnourished at baseline, defined as a mid-upper arm circumference in the red zone of the paper tape or a weight-for-age or height-for-age z-score of less than or equal to -3.0, the child will be excluded from the study due to malnutrition, and the parents will be advised to take the child to the nearest malnutrition clinic

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University

    Boston, Massachusetts, 02111

Other trials in United States

About this study

This study is a randomized controlled pilot for a future larger trial. The goals of this pilot are: a) to assess feasibility of delivering a locally prepared supplement in rural communities, and b) to generate pilot data for sample size estimates needed for a larger trial. The study will test the effect of a supplement prepared locally with local and imported ingredients on changes in standard anthropometric benchmarks of growth, cognition, immune function, hemoglobin and skin carotenoids in young children living in 2 villages in rural Guinea-Bissau. Children in the active intervention village will be compared with assessment-only controls in a separate village having comparable demographic characteristics. As part of the study, we will assess the feasibility of having local commercial bakers prepare the supplement.

Read the detailed description

Up to 20 children aged 24-30 months and 20 school children aged 6-6.5 years living in each of 2 villages in the Oio region of Guinea-Bissau (total study population up to 80, with no minimum recruitment number) will be recruited for this study, with ages documented by the official birth record, which all families possess. Villages will be a convenience sample chosen from villages within the network of our local research partner International Partnership for Human Development. Each village in this region has one school and one community health center per village, which will be involved in supplement distribution and some outcome assessments. The villages will be broadly comparable in terms of size, affluence, rates of malnutrition, the presence or absence of a school meal program, and tribal affiliation and religion.

One village will be randomly assigned to receive the locally-prepared biscuit and a daily multivitamin and the other will be randomly assigned to be an assessment-only control site. Because this is a pilot study designed to develop methodology for a future powered trial, and the logistics of local supplement preparation need to be developed in advance of the study, the randomization will occur prior to baseline testing to allow for development of infrastructure for supplement preparation. However the villagers will not be informed of the randomization until after baseline testing is complete.

Following baseline measurements of anthropometry, grip strength, cognition, non-invasive measurements of hemoglobin, and skin carotenoids, participants will receive their intervention for 12 weeks and the same measurements taken at baseline will be repeated during the last study week. Since access for the final assessment to villages may be hampered by the rainy season we also request permission to terminate the trial between 9-12 weeks of supplement consumption depending on weather conditions. Please note that cell phone access to villages is not influenced by local weather, thus communication regarding safety issues with community health workers will remain possible throughout the entire trial.

Conditions
Malnutrition
Being tested
Supplement
Medical subject headings
Malnutrition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SupplementDietary supplement

    locally prepared biscuit with low sugar content (less than 10% weight) designed to facilitate growth and cognitive development

Study groups in NCT03319589
Study groupRoleWhat they receive
Supplement ArmExperimentalSchool children (age 6 to 6.5) will receive their supplement 5 days a week in the morning before school starts. They will either receive the supplement at school or at the community health center depending on the preference of the villagers after recruitment. Young children (age 24 to 30 months) will receive the supplement 5 days a week in the morning at the community health center, distributed by community health workers.
Receives: Dietary Supplement: Supplement
Control ArmNo interventionChildren in the active intervention village will be compared with assessment-only controls in a separate village having comparable demographic characteristics

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in executive cognitive function

    Two measures of executive function, working memory and task-switching abilities, will be administered through play-based games by local research team members. "Spin the Pots" and "Reverse Categorization" tasks, modeled after Carlson et al., have been age modified and culturally adopted.

    Measured: Baseline and end line (12 weeks difference)

Secondary outcomes (18)
  1. Supplementation Attendance

    community health workers will record attendance of children to consume the supplement.

    Measured: Through study completion (12 weeks)

  2. Sicknesses

    Community health workers will record sickness (malaria, stomach issues, fever) if children to consume the supplement are unwell.

    Measured: Through study completion (12 weeks)

  3. Change in hand grip strength

    . In the children aged 6-6.5 years, grip strength in both hands will be measured in duplicate using a dynamometer suitable for pediatric populations

    Measured: Baseline and end line (12 weeks difference)

  4. Change in Hemoglobin

    Hemoglobin will be measured non-invasively using a standard technique that uses light of different wavelengths directed at the finger

    Measured: Baseline and end line (12 weeks difference)

  5. Change in skin carotenoids

    a non-invasive optical measure of carotenoids in tissue, measured by shining light in the palm of the hand

    Measured: Baseline and end line (12 weeks difference)

  6. Change in immune function

    In this study we will measure delayed-type hypersensitivity (DTH) response using a standard Mantoux test composed of 3 antigens and a negative control via 4 intradermal skin injections that will be performed at baseline and the end of the study

    Measured: Baseline and end line (12 weeks difference)

  7. Food Product Acceptability

    Mothers (for the young children) and school children will be asked on a 4-point scale of '1=not at all' '2=a little', '3=moderately' and '4=very much' how much they enjoy eating the two types biscuits and the multivitamin. Preference for one biscuit over another will be determined by a higher total summed up score. The biscuit with a greater score will be used during the study.

    Measured: Baseline

  8. Mother's Height Change

    Height of the mothers measured in cm.

    Measured: Baseline and end line (12 weeks difference)

  9. Mother's Weight Change

    Weight of the mothers measured in kg.

    Measured: Baseline and end line (12 weeks difference)

  10. Mother's MUAC change

    The weight, height and MUAC of the mothers will also be measured, and family demographic data (family size, number of wives and children and ages) will be collected by questioning the mother.

    Measured: Baseline and end line (12 weeks difference)

  11. Family Demographics Change

    Family demographic data (family size, number of wives and children and ages) will be collected by questioning the mother.

    Measured: Baseline and end line (12 weeks difference)

  12. Photographs

    Parents (and children, in the case of the school children) will be asked for permission to take photographs of them that illustrate the outcome measurements and supplement consumption, for the purpose of using in presentations on the research.

    Measured: through study completion, 12 weeks

  13. Change in weight

    Multiple measurements of weight to ±0.1 kg will be taken using a calibrated digital scale

    Measured: Baseline and end line (12 weeks difference)

  14. Change in height

    Duplicate measures of height will be made with an upright stadiometer measuring to 0.1 cm

    Measured: Baseline and end line (12 weeks difference)

  15. Change in circumferences

    Duplicate measurements of mid-upper arm circumference (MUAC) will be taken at the midpoint between the acromion process of scapula and olecranon process, and head circumference will be measured in duplicate at the widest diameter, using standardized World Health Organization (WHO) methods.

    Measured: Baseline and end line (12 weeks difference)

  16. Brain Hemoglobin

    Near infrared spectroscopy

    Measured: Endline at up to 12 weeks

  17. Brain Oxygenation

    Near infrared spectroscopy

    Measured: Endline at up to 12 weeks

  18. Brain Blood Flow

    Near infrared spectroscopy

    Measured: Endline at up to 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Oct 2017
  2. Study startMar 2016
  3. Primary completionJun 2016
  4. Study completionJul 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03319589
Sponsor's protocol ID
1200
Status last verified
Oct 2017
First submitted
11 Mar 2016
Last updated
24 Oct 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Supplement in people with Malnutrition, run by Tufts University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in executive cognitive function (time frame: Baseline and end line (12 weeks difference)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Oct 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in